Study of the immunogenicity, efficacy and safety of recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in rodent, non-rodent and Maccaca fascicularis using Indonesian Strain Virus
Nur Amalia Limeilati, Reviany V. Nidom, Trilokita Tunjung Sari, Nurvita Putih Kusumarahayu, Siti V. Fransiska, Setyarina Indrasari, Afrillia Nuryanti Garmana, Dhyan K. Ayuningtyas, Gembong S. Nugroho, Darsono Darsono, Maharani Maharani, Acep Riza Wijayadikusumah, Elin Yulinah, I Ketut Adyana, Astria Novitasari Nidom, , Chairul Anwar Nidom
This study evaluates the immunogenicity, efficacy, and safety of a recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in various animal models, showing significant antibody responses and protection against infection.
bioRxiv · Dec 18, 2024 · PreprintImmunology